posted
Cambridge Heart (OTCBB-CAMH) today announced that it has received clearance from the U.S. Food and Drug Administration to begin marketing in the United States of its new Heartwave II System for the measurement of Microvolt T-Wave Alternans (MTWA). Product availability is immediate
IP: Logged |